| Income Statement | 2025-07-31 | 2024-10-31 | 2024-07-31 | |
|---|---|---|---|---|
| Loss on disposal of equipment | -20 | - | - | |
| Total costs and operating expenses | 14,522 | 12,757 | 12,732 | |
| (loss) income from operations | -527 | 732 | 1,329 | |
| Other income, net | 75 | 7 | 5 | |
| (loss) income before provision for income taxes | -452 | 739 | 1,334 | |
| Provision for income taxes | 14 | 11 | 21 | |
| Net (loss) income | -466 | - | - | |
| Less net loss attributable to noncontrolling interest | -30 | - | - | |
| Net (loss) income attributable to company's common shares | -436 | 728 | 1,313 | |
| And diluted (in shares) | 13,788,414 | 14,016,953 | 14,042,379 | |
| Basic (in dollars per share) | -0.03 | 0.05 | 0.1 | |
| Basic (in shares) | 13,788,414 | 13,593,766 | 13,593,766 | |
| Diluted (in dollars per share) | -0.03 | 0.05 | 0.09 | |
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)